Skip to content

Laparoscopic Versus Transvaginal Closure of the Vaginal Vault After Total Laparoscopic Hysterectomy

Laparoscopic Versus Transvaginal Closure of the Vaginal Vault After Total Laparoscopic Hysterectomy - a Single Blinded Randomized Comparative Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06867614
Enrollment
48
Registered
2025-03-10
Start date
2025-01-14
Completion date
2026-01-19
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Laparoscopic Hysterectomy

Brief summary

The goal of this clinical trial is to compare the laparoscopic and transvaginal closure techniques of the vaginal vault in patients who perform TLH, regarding the risk of vaginal vault hematoma and other complications as vaginal cuff infection and sexual dysfunction.

Interventions

PROCEDURETotal laparoscopic hysterectomy

Removal of uterus and cervix by laparoscope

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Adult females consenting to do TLH all age groups with diagnoses of benign uterine conditions. * Women who are non-obese (normal or overweight women with BMI range 18-29.9). * Sexually active female.

Exclusion criteria

* Diagnosed cases of pelvic malignancy * Diagnosed patients with Cervical intraepithelial neoplasia (CIN) or bacterial vaginosis (any infection should be treated) * Obese patients. * Patients currently undergoing treatment for any type of cancer * Patients with coagulopathy, bleeding/clotting disorders * Patients with any condition can impair wound healing: diabetes mellites, anemia, steroids * Patients with a previous history of radiation and allergy to sutures * Patients with clinically evident prolapse

Design outcomes

Primary

MeasureTime frameDescription
Vaginal Vault hematomaFrom 10 days postoperative to 30 days postoperativeIt will be assessed by examination and ultrasound

Secondary

MeasureTime frameDescription
Vaginal cuff granulationFrom 10 days postoperative to 30 days postoperativeIt will be assessed by examination and ultrasound
Bleeding/spottingFrom 10 days postoperative to 30 days postoperativeI wil be assed by history and examination
Vaginal infection:From 10 days postoperative to 30 days postoperativeIt will be assessed by history and examination
Vaginal prolapseFrom 10 days postoperative to 30 days postoperativeIt will be assessed by history and examination
Sexual dysfunctionFrom 3 to 4 months post operativeI will be assessed through Female Sexual Function Index (FSFI) questionnaire

Countries

Egypt

Contacts

Primary ContactRowan A Sakr
150232@med.asu.edu.eg+201026141345

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026